Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Nephros (NEPH) Other Non Operating Income (2016 - 2025)

Nephros has reported Other Non Operating Income over the past 16 years, most recently at -$10000.0 for Q4 2025.

  • Quarterly results put Other Non Operating Income at -$10000.0 for Q4 2025, down 152.63% from a year ago — trailing twelve months through Dec 2025 was -$78000.0 (down 680.0% YoY), and the annual figure for FY2025 was -$78000.0, down 680.0%.
  • Other Non Operating Income for Q4 2025 was -$10000.0 at Nephros, up from -$15000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for NEPH hit a ceiling of $72000.0 in Q2 2022 and a floor of -$465000.0 in Q4 2021.
  • Median Other Non Operating Income over the past 5 years was -$9500.0 (2022), compared with a mean of -$25850.0.
  • Biggest five-year swings in Other Non Operating Income: plummeted 1560.71% in 2021 and later skyrocketed 7300.0% in 2022.
  • Nephros' Other Non Operating Income stood at -$465000.0 in 2021, then skyrocketed by 93.55% to -$30000.0 in 2022, then decreased by 6.67% to -$32000.0 in 2023, then surged by 159.38% to $19000.0 in 2024, then plummeted by 152.63% to -$10000.0 in 2025.
  • The last three reported values for Other Non Operating Income were -$10000.0 (Q4 2025), -$15000.0 (Q3 2025), and -$32000.0 (Q2 2025) per Business Quant data.